Evidence map›Paper›PMID 42539813›Full record

ArticleHuman mutation2026

Mahim Hassan Chowdhury, Faria Billal Shaolin, Nishat Tabassum Khusbu, Upama Gope Puja, Md Sharif Hossain, Md Robiul Islam, Akash Majumder, Shah Musallin Hassan, Mohiuddin Ahmed Bhuiyan, Md Aminul Haque

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human mutation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Mahim Hassan ChowdhuryResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.ORCID https://orcid.org/0009-0002-4906-2985
Faria Billal ShaolinResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.
Nishat Tabassum KhusbuResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.ORCID https://orcid.org/0009-0007-2656-7127
Upama Gope PujaResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.
Md Sharif HossainResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.ORCID https://orcid.org/0009-0007-9391-3464
Md Robiul IslamResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.
Akash MajumderResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.
Shah Musallin HassanResearch Lab, Rufaida BioMeds, Dhaka, Bangladesh.
Mohiuddin Ahmed BhuiyanDepartment of Pharmacy, University of Asia Pacific, Dhaka, Bangladesh, uap-bd.edu.ORCID https://orcid.org/0000-0002-2218-4061
Md Aminul HaqueSchool of Pharmacy, BRAC University, Dhaka, Bangladesh, bracu.ac.bd.ORCID https://orcid.org/0000-0002-1680-3006

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer (BC) is one of the most common and deadly cancers affecting women worldwide. This study is aimed at investigating the association between BC risk and two single nucleotide polymorphisms (SNPs):

Indexed as

Breast NeoplasmsEstrogen Receptor alphaGenetic Predisposition to DiseasePhosphatidylinositol 3-KinasesPolymorphism, Single NucleotideAdultBangladeshCase-Control StudiesClass I Phosphatidylinositol 3-KinasesFemaleGene FrequencyGenetic Association StudiesGenotypeHumansMiddle AgedRisk FactorsClass I Phosphatidylinositol 3-KinasesESR1 protein, humanEstrogen Receptor alphaPhosphatidylinositol 3-KinasesPIK3CA protein, humanbreast cancercancer riskESR1 genegenetic markerPIK3CA geneSNP

Identifiers

PMID42539813
PMCPMC13424455

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.